Drugmaker GSK buys US vaccine firm for up to $3.3 bn
New studies shed light on election-related stress
31 May 2022Suspected suicide attempts by poisoning among US children rose 26.7% from 2015 to 2020, study finds
31 May 2022Drugmaker GSK buys US vaccine firm for up to $3.3 bn
British drugmaker GlaxoSmithKline on Tuesday snapped up US biopharmaceutical firm Affinivax for up to $3.3 billion, expanding further into vaccines before the demerger of its consumer health care arm.
